首页> 外国专利> COMPOSITIONS AND METHODS OF ENHANCING OPIOID RECEPTOR ENGAGEMENT BY OPIOID HEXADIENOATES AND OPTIONALLY SUBSTITUTED HEXADIENOATES

COMPOSITIONS AND METHODS OF ENHANCING OPIOID RECEPTOR ENGAGEMENT BY OPIOID HEXADIENOATES AND OPTIONALLY SUBSTITUTED HEXADIENOATES

机译:增强阿片类六丁烯和任选取代的六种戊二烯与阿片样物质受体结合的组合物和方法

摘要

The present invention relates to opiate derived compositions and their antagonists useful in therapeutic areas associated with opioid receptor modulation,;A 3-hexadienoate modification of the opioids is formulated to improve opiates' engagement of the opioid receptors when given orally. A 3-hexadienoate modification of Nalbuphine or a pharmaceutically acceptable salt of thereof to improve quality of pain management when given intravenously, intranasally, transdermally, sublingually, rectally, topically, intramuscularly, subcutaneously or via inhalation.;A 3-hexadienoate modification of the opioids antagonists is formulated to improve inhibition of the opioid receptors when given orally. A 3-hexadienoate modification of Naloxone or a pharmaceutically acceptable salt of thereof to improve quality of Sobering when given intravenously, intranasally, transdermally, sublingually, rectally, topically, intramuscularly, subcutaneously or via inhalation.
机译:本发明涉及鸦片来源的组合物及其拮抗剂,其可用于与阿片样物质受体调节有关的治疗领域。配制阿片样物质的3-己二酸酯修饰以改善口服给药时阿片样物质对阿片样物质受体的参与。 Nalbuphine的3-己二酸酯修饰或其药学上可接受的盐,可在静脉内,鼻内,经皮,舌下,直肠,局部,肌肉内,皮下或通过吸入给药时改善疼痛控制的质量;阿片类药物的3-己二酸酯修饰口服时,可以配制拮抗剂来改善对阿片受体的抑制作用。当通过静脉内,鼻内,经皮,舌下,直肠,局部,肌肉内,皮下或通过吸入给药时,纳洛酮或其药学上可接受的盐的3-己二酸酯修饰以提高清醒的质量。

著录项

  • 公开/公告号US2020055864A1

    专利类型

  • 公开/公告日2020-02-20

    原文格式PDF

  • 申请/专利权人 KAPPA-PHARMA LLC;

    申请/专利号US201916540058

  • 申请日2019-08-14

  • 分类号C07D489/02;C07C229/38;C07D221/28;A61P25/36;

  • 国家 US

  • 入库时间 2022-08-21 11:22:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号